MX9709347A - Micoplasma synoviae no virulento y vacuna del mismo. - Google Patents

Micoplasma synoviae no virulento y vacuna del mismo.

Info

Publication number
MX9709347A
MX9709347A MX9709347A MX9709347A MX9709347A MX 9709347 A MX9709347 A MX 9709347A MX 9709347 A MX9709347 A MX 9709347A MX 9709347 A MX9709347 A MX 9709347A MX 9709347 A MX9709347 A MX 9709347A
Authority
MX
Mexico
Prior art keywords
synovial mycoplasma
synovial
mycoplasma
vaccine
same
Prior art date
Application number
MX9709347A
Other languages
English (en)
Other versions
MXPA97009347A (es
Inventor
Maarten Hendrik Witvliet
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MX9709347A publication Critical patent/MX9709347A/es
Publication of MXPA97009347A publication Critical patent/MXPA97009347A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion provee Mycoplasma synoviae independiente de NAD de la cepa MS1. La invencion también se refiere a cultivos microbiologicos que comprenden Mycoplasma synoviae de esta cepa. Después de esto, la invencion se refiere a vacunas vivas derivadas de estas cepas, para la proteccion de aves contra infeccion de Mycoplasma synoviae. Además, la invencion provee métodos para la preparacion de dichas vacunas. También, se describe el uso de cepas de Mycoplasma synoviae independientes de NAD para la preparacion de vacunas vivas para la proteccion de aves contra infeccion de Mycoplasma synoviae.
MXPA/A/1997/009347A 1996-12-05 1997-12-01 Micoplasma synoviae no virulento y vacuna del mismo MXPA97009347A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96203441 1996-12-05
NL96203441.9 1996-12-05

Publications (2)

Publication Number Publication Date
MX9709347A true MX9709347A (es) 1998-06-30
MXPA97009347A MXPA97009347A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
DE69729425D1 (de) 2004-07-15
HUP9702355A3 (en) 2003-03-28
ZA9710606B (en) 1998-06-12
HU223274B1 (hu) 2004-04-28
HU9702355D0 (en) 1998-03-02
PT846468E (pt) 2004-09-30
HUP9702355A2 (hu) 1998-09-28
AU717062B2 (en) 2000-03-16
DE69729425T2 (de) 2005-06-09
CA2222482C (en) 2005-06-07
US6001348A (en) 1999-12-14
IL122587A0 (en) 1998-06-15
BR9706133A (pt) 1999-04-27
BR9706133B1 (pt) 2009-01-13
IL122587A (en) 2000-08-13
JP3945885B2 (ja) 2007-07-18
AR009650A1 (es) 2000-04-26
AU4684397A (en) 1998-06-11
CA2222482A1 (en) 1998-06-05
JPH10179144A (ja) 1998-07-07
ES2222497T3 (es) 2005-02-01
ATE268606T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
PT672116E (pt) Mutantes por supressao como vacinas contra a colera
HUP9901112A2 (hu) Szintetikus HIV-gének
MX9700229A (es) Vacuna de polinucleotido para virus de papiloma.
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
IL123264A0 (en) Multi-subtype FIV vaccines
CA2222482A1 (en) Non-virulent mycoplasma synoviae and vaccine thereof
AU3478393A (en) Vaccine containing acemannan as an adjuvant
ATE270112T1 (de) Streptococcus equi impfstoff
WO2000045840A8 (en) Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
BR9909076A (pt) Vìrus atenuado do sarampo, recombinantemente gerado, isolado, vìrus do sarampo, vìrus sincicial respiratório humano (rsv), subgrupo b, atenuado, recombinantemente gerado, isolado, o rsv, subgrupo b, vacina processo para imunização de um indivìduo para induzir proteção contra vìrus do sarampo, processo para imunização de um indivìduo para induzir proteção contra o rsv, subgrupo b, composição, processo para produção de vìrus do sarampo infeccioso atenuado, processo para produção de rsv infeccioso atenuado subgrupo b
WO2002047720A3 (en) Treatment and prevention of ebv infection and ebv-associated disorders
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
IL122829A0 (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
DK0929315T3 (da) Krydsbeskyttende equine herpesviruspræparater, deres fremstilling og anvendelse
EP0178928A3 (en) Vaccines
UA30385A (uk) Штам вірусу інфекційного ринотрахеїту ipt-lg /іеквм/ для виготовлення вакцини
GB9919732D0 (en) Trehalose producing cells as vaccines
AU3970099A (en) Avian polyomavirus vaccines in psittacine birds
UA67249A (en) Strain paramixovirus-3 bovis "m-87" for the preparation of vaccine and diagnostic antigen
AP1679A (en) Outer surface proteins, their genes, and their use.
MX9604262A (es) Antigenos de pasteurellaceae y vacunas relacionadas.